Viral infections in wheezing disorders

European Respiratory Review

Volumn 27, Issue 147, 2018, Pages

  Le Souëf, Peter ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; OMALIZUMAB; PALIVIZUMAB; PLACEBO; PREDNISOLONE; RHINOVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT; GLUCOCORTICOID; IMMUNOLOGICAL ADJUVANT;

ARTICLE; ASTHMA; CLINICAL OUTCOME; CORYNEBACTERIUM; DISEASE EXACERBATION; FUNDING; HUMAN; IMMUNIZATION; IMMUNOMODULATION; MICROBIOME; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS GENOME; VIRUS LOAD; WHEEZING; ABNORMAL RESPIRATORY SOUND; DRUG EFFECT; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG; PATHOGENICITY; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFECTION; RISK FACTOR; TREATMENT OUTCOME; VIROLOGY; VIRUS; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; GLUCOCORTICOIDS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNIZATION; LUNG; RESPIRATORY SOUNDS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; TREATMENT OUTCOME; VIRAL LOAD; VIRAL VACCINES; VIRUS DISEASES; VIRUSES;

EID: 85053730636     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0133-2017     Document Type: Article

References (33)

1. Thompson SP. The life of Lord Kelvin (Originally published 1910, reissued 1976). 2nd Edn. Providence, AMS Chelsea Publishing/American Mathematical Society, 1976.
2. Griggs TF, Bochkov YA, Basnet S, et al. Rhinovirus C targets ciliated airway epithelial cells. Respir Res 2017; 18: 84.
3. Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol 2012; 130: 489–495.
4. Edwards MR, Regamey N, Vareille M, et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 2013; 6: 797–806.
5. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201: 937–947.
6. Johnston SL. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc Am Thorac Soc 2007; 4: 267–270.
7. Pang LL, Yuan XH, Shao CS, et al. The suppression of innate immune response by human rhinovirus C. Biochem Biophys Res Commun 2017; 490: 22–28.
8. Oyston P, Robinson K. The current challenges for vaccine development. J Med Microbiol 2012; 61: 889–894.
9. Lee S, Nguyen MT, Currier MG, et al. A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques. Nature Commun 2016; 7: 12838.
10. Bizzintino J, Lee W-M, Laing IA, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011; 37: 1037–1042.
11. Koistinen A, Lukkarinen M, Turunen R, et al. Prednisolone for the first rhinovirus-induced wheezing and 4-year asthma risk: a randomized trial. Pediatr Allergy Immunol 2017; 28: 557–563.
12. Mochizuki H, Kusuda S, Okada K, et al. Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing. six-year follow-up study. Am J Respir Crit Care Med 2017; 196: 29–38.
13. Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65: 1045–1052.
14. Simoes EA, Carbonell-Estrany X, Rieger CH, et al. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010; 126: 256–262.
15. Brini I, Guerrero A, Hannachi N, et al. Epidemiology and clinical profile of pathogens responsible for the hospitalization of children in Sousse area, Tunisia. PLoS One 2017; 12: e0188325.
16. Esquivel A, Busse WW, Calatroni A, et al. Effects of omalizumab on rhinovirus infections, illnesses and exacerbations of asthma. Am J Respir Crit Care Med 2017; 196: 985–992.
17. Message SD, Johnston SL. The immunology of virus infection in asthma. Eur Respir J 2001; 18: 1013–1025.
18. Gill MA, Liu AH, Calatroni A, et al. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol 2017; 18: in press [https://doi.org/10.1016/j.jaci.2017.07.035].
19. Annamalay AA, Lanaspa M, Khoo SK, et al. Rhinovirus species and clinical features in children hospitalised with pneumonia from Mozambique. Trop Med Int Health 2016; 21: 1171–1180.
20. Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347: 869–877.
21. Lu Y, Li Y, Xu L, et al. Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children. Pharmacology 2015; 95: 139–144.
22. Razi CH, Harmanci K, Abaci A, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 2010; 126: 763–769.
23. Velasquez-Manoff M. Gut microbiome: the peacekeepers. Nature 2015; 518: S3–S11.
24. Gollwitzer ES, Marsland BJ. Microbiota abnormalities in inflammatory airway diseases – potential for therapy. Pharmacol Ther 2014; 141: 32–39.
25. Dang AT, Pasquali C, Ludigs K, et al. OM-85 is an immunomodulator of interferon-β production and inflammasome activity. Sci Rep 2017; 7: 43844.
26. Parola C, Salogni L, Vaira X, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One 2013; 8: e82867.
27. Liu C, Huang R, Yao R, et al. The immunotherapeutic role of bacterial lysates in a mouse model of asthma. Lung 2017; 195: 563–569.
28. University of Arizona. Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX). https://clinicaltrials.gov/ct2/show/NCT02148796 Date last updated: Jan 20 2017.
29. Kloepfer KM, Sarsani VK, Poroyko V, et al. Community-acquired rhinovirus infection is associated with changes in the airway microbiome. J Allergy Clin Immunol 2017; 140: 312–315.
30. Karppinen S, Terasjarvi J, Auranen K, et al. Acquisition and transmission of Streptococcus pneumoniae is facilitated during rhinovirus infection in families with children. Am J Respir Crit Care Med 2017; 196: 1172–1180.
31. Mitchell AB, Oliver BG, Glanville AR. Translational aspects of the human respiratory virome. Am J Respir Crit Care Med 2016; 194: 1458–1464.
32. Zhou Y, Fernandez S, Yoon IK, et al. Metagenomics study of viral pathogens in undiagnosed respiratory specimens and identification of human enteroviruses at a Thailand hospital. Am J Trop Med Hyg 2016; 95: 663–669.
33. Faner R, Sibila O, Agusti A, et al. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J 2017; 49: 1602086.